Comparison of visual quality after wavefront-guided LASIK in patients with different levels of preoperative total ocular higher-order aberrations: a retrospective study.


Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2024
Historique:
received: 16 05 2024
accepted: 28 07 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

To compare the visual quality after wavefront-guided femtosecond LASIK (WFG FS-LASIK) in patients with different levels of preoperative total ocular higher-order aberrations to guide clinical decision-making regarding patient selection and treatment strategies. This study included 112 right eyes of 112 patients who previously underwent WFG FS-LASIK for correcting myopia and myopic astigmatism. The patients were divided into two groups based on the mean values of preoperative total ocular HOAs (0.30 ± 0.09 µm): HOA ≤ 0.3 and > 0.3 groups. The visual acuity, manifest refraction, corneal Strehl ratio (SR), root mean square (RMS) of corneal and ocular aberrations, and area under the log contrast sensitivity function (AULCSF) of both groups were compared preoperatively and at 1, 3, 6, and 12 months postoperatively. The induced ocular HOAs and coma (Δ = 1 mo - Preop) were significantly lower in the HOAs > 0.3 group than in the HOAs ≤ 0.3 group (ΔHOAs: 0.39 ± 0.19 The induced ocular HOAs and coma in HOAs > 0.3 group were lower. However, both groups achieved equivalent and excellent visual quality after WFG FS-LASIK. WFG FS-LASIK may provide significant visual benefits for a wider range of patients.

Identifiants

pubmed: 39184392
doi: 10.7717/peerj.17940
pii: 17940
pmc: PMC11344536
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17940

Informations de copyright

© 2024 Zhang et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Yu Zhang (Y)

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Medal Eye Institute, Chongqing, China.

Yangrui Du (Y)

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Medal Eye Institute, Chongqing, China.

Ming He (M)

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Youdan Zhang (Y)

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zhiyu Du (Z)

Department of Ophthalmology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH